MLAB - Mesa Laboratories Inc Stock Price, Fair Value and News

109.25USD+1.06 (+0.98%)Market Closed

Market Summary

USD109.25+1.06

Market Closed

0.98%

MLAB Stock Price

View Fullscreen

MLAB RSI Chart

MLAB Valuation

Market Cap

590.9M

Price/Earnings (Trailing)

-2.32

Price/Sales (Trailing)

2.73

EV/EBITDA

-2.76

Price/Free Cashflow

14.22

MLAB Price/Sales (Trailing)

MLAB Profitability

Operating Margin

61.64%

EBT Margin

-127.50%

Return on Equity

-174.87%

Return on Assets

-56.9%

Free Cashflow Yield

7.03%

MLAB Fundamentals

MLAB Revenue

Revenue (TTM)

216.2M

Rev. Growth (Yr)

5.96%

Rev. Growth (Qtr)

10.16%

MLAB Earnings

Earnings (TTM)

-254.2M

Earnings Growth (Yr)

-41.8K%

Earnings Growth (Qtr)

-12.1K%

Breaking Down MLAB Revenue

Last 7 days

1.1%

Last 30 days

23.9%

Last 90 days

5.9%

Trailing 12 Months

-14.5%

How does MLAB drawdown profile look like?

MLAB Financial Health

Current Ratio

2.47

Debt/Equity

1.18

Debt/Cashflow

0.26

MLAB Investor Care

Dividend Yield

0.59%

Dividend/Share (TTM)

0.64

Shares Dilution (1Y)

0.73%

Diluted EPS (TTM)

-47.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	216.2M	0	0	0
2023	219.1M	219.3M	213.7M	212.9M
2022	184.3M	199.9M	222.8M	222.4M
2021	133.9M	138.9M	142.9M	163.4M
2020	117.7M	121.3M	127.7M	130.2M
2019	103.1M	104.3M	105.0M	109.9M
2018	96.2M	98.6M	100.6M	103.6M
2017	93.7M	95.2M	93.8M	93.6M
2016	84.7M	87.6M	90.2M	94.2M
2015	71.3M	73.1M	76.3M	78.4M
2014	52.7M	57.9M	63.8M	68.5M
2013	46.4M	47.1M	48.1M	49.8M
2012	39.6M	40.9M	42.9M	44.6M
2011	34.2M	35.7M	37.4M	39.0M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Mesa Laboratories Inc

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

CEO	Mr. Gary M. Owens
WEBSITE	mesalabs.com
INDUSTRY	Consumer Electronics
EMPLOYEES	698

Mesa Laboratories Inc Frequently Asked Questions

What is the ticker symbol for Mesa Laboratories Inc? What does MLAB stand for in stocks?

MLAB is the stock ticker symbol of Mesa Laboratories Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Mesa Laboratories Inc (MLAB)?

As of Fri Jul 26 2024, market cap of Mesa Laboratories Inc is 590.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MLAB stock?

You can check MLAB's fair value in chart for subscribers.

Is Mesa Laboratories Inc a good stock to buy?

The fair value guage provides a quick view whether MLAB is over valued or under valued. Whether Mesa Laboratories Inc is cheap or expensive depends on the assumptions which impact Mesa Laboratories Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MLAB.

What is Mesa Laboratories Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, MLAB's PE ratio (Price to Earnings) is -2.32 and Price to Sales (PS) ratio is 2.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MLAB PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Mesa Laboratories Inc's stock?

In the past 10 years, Mesa Laboratories Inc has provided 0.035 (multiply by 100 for percentage) rate of return.